| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.8M | +127.3% |
| Cost of Revenue | $14.8M | +65.6% |
| Gross Profit | -$2.0M | +39.0% |
| R&D Expense | $6.4M | -24.8% |
| SG&A Expense | $12.6M | +7.6% |
| Operating Income | -$26.3M | +17.8% |
| Pre-tax Income | -$22.1M | +13.7% |
| Net Income | -$22.1M | +13.7% |
| EPS (Basic) | -$0.34 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.3M | -52.6% |
| Accounts Receivable | $2.1M | +52.6% |
| Inventory | $2.3M | -9.4% |
| Current Assets | $8.2M | -18.6% |
| Total Assets | $23.0M | +4.0% |
| Current Liabilities | $6.9M | -33.9% |
| Long-term Debt | $1.2M | -85.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.2M | -0.4% |
| Capital Expenditures | $457K | +311.7% |
| Investing Cash Flow | -$5.1M | +48.4% |
| Financing Cash Flow | $26.8M | -4.0% |
| Free Cash Flow | -$24.6M | -1.8% |
| +52.8% |
| EPS (Diluted) | -$0.34 | +52.8% |
| Total Liabilities |
| $15.4M |
| -48.5% |
| Stockholders' Equity | -$26.6M | +38.9% |